---
title: "WILDMAN DANIEL GEORGE — Ownership Dossier"
canonical: https://whiteintel.dev/entity/30fa22e0-673d-5bdf-b2a3-06cfb1be6dd4
json: https://whiteintel.dev/api/public/dossier/30fa22e0-673d-5bdf-b2a3-06cfb1be6dd4
identifier: sec:0001952679
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# WILDMAN DANIEL GEORGE

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001952679`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/30fa22e0-673d-5bdf-b2a3-06cfb1be6dd4  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/30fa22e0-673d-5bdf-b2a3-06cfb1be6dd4  

## Ownership & control

### Holdings / subsidiaries

- **UroGen Pharma Ltd.** (director) — https://whiteintel.dev/entity/bf2a7758-71ca-5124-a94c-78b2086c2b93

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **WILDMAN DANIEL GEORGE**. Human view: https://whiteintel.dev/entity/30fa22e0-673d-5bdf-b2a3-06cfb1be6dd4 · Structured JSON: https://whiteintel.dev/api/public/dossier/30fa22e0-673d-5bdf-b2a3-06cfb1be6dd4._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._